Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adrian L Harris

Showing results (191-200 of 464) with videos related to

Pageof 47
Sort By:
Histopathology|February 3, 2012
Expression of vascular Notch ligands Delta-like 4 and Jagged-1 in glioblastomaAdrian M Jubb, Lisa Browning, Leticia Campo, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 4, 2009
Hypoxic activation of the unfolded protein response (UPR) induces expression of the metastasis-associated gene LAMP3Hilda Mujcic, Tomasz Rzymski, Kasper M A Rouschop, et al.
Cancers|April 30, 2021
Unveiling Cancer Metabolism through Spontaneous and Coherent Raman Spectroscopy and Stable Isotope ProbingJiabao Xu, Tong Yu, Christos E Zois, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 27, 2004
Expression of the forkhead transcription factor FOXP1 is associated with estrogen receptor alpha and improved survival in primary human breast carcinomasStephen B Fox, Philip Brown, Cheng Han, et al.
The Journal of Pathology|May 20, 2003
DEC1 (STRA13) protein expression relates to hypoxia- inducible factor 1-alpha and carbonic anhydrase-9 overexpression in non-small cell lung cancerAlexandra Giatromanolaki, Michael I Koukourakis, Efthimios Sivridis, et al.
Oncotarget|August 26, 2015
Carbonic anhydrase IX induction defines a heterogeneous cancer cell response to hypoxia and mediates stem cell-like properties and sensitivity to HDAC inhibitionIoanna Ledaki, Alan McIntyre, Simon Wigfield, et al.
EJNMMI Research|June 1, 2017
Monitoring response to anti-angiogenic mTOR inhibitor therapy in vivo using <sup>111</sup>In-bevacizumabNeel Patel, Sarah Able, Danny Allen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 6, 2009
Phase I/II trial of bevacizumab and radiotherapy for locally advanced inoperable colorectal cancer: vasculature-independent radiosensitizing effect of bevacizumabMichael I Koukourakis, Alexandra Giatromanolaki, Helen Sheldon, et al.
Cancer Research|March 15, 2008
Regulation of CXCR4 by the Notch ligand delta-like 4 in endothelial cellsCassin Kimmel Williams, Marta Segarra, Maria De La Luz Sierra, et al.
International Journal of Radiation Oncology, Biology, Physics|July 20, 2002
Hypoxia-inducible factor (HIF1A and HIF2A), angiogenesis, and chemoradiotherapy outcome of squamous cell head-and-neck cancerMichael I Koukourakis, Alexandra Giatromanolaki, Efthimios Sivridis, et al.
Pageof 47

Showing results (191-200 of 464) with videos related to

Sort By:
Pageof 47
Histopathology|February 3, 2012
Expression of vascular Notch ligands Delta-like 4 and Jagged-1 in glioblastomaAdrian M Jubb, Lisa Browning, Leticia Campo, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 4, 2009
Hypoxic activation of the unfolded protein response (UPR) induces expression of the metastasis-associated gene LAMP3Hilda Mujcic, Tomasz Rzymski, Kasper M A Rouschop, et al.
Cancers|April 30, 2021
Unveiling Cancer Metabolism through Spontaneous and Coherent Raman Spectroscopy and Stable Isotope ProbingJiabao Xu, Tong Yu, Christos E Zois, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 27, 2004
Expression of the forkhead transcription factor FOXP1 is associated with estrogen receptor alpha and improved survival in primary human breast carcinomasStephen B Fox, Philip Brown, Cheng Han, et al.
The Journal of Pathology|May 20, 2003
DEC1 (STRA13) protein expression relates to hypoxia- inducible factor 1-alpha and carbonic anhydrase-9 overexpression in non-small cell lung cancerAlexandra Giatromanolaki, Michael I Koukourakis, Efthimios Sivridis, et al.
Oncotarget|August 26, 2015
Carbonic anhydrase IX induction defines a heterogeneous cancer cell response to hypoxia and mediates stem cell-like properties and sensitivity to HDAC inhibitionIoanna Ledaki, Alan McIntyre, Simon Wigfield, et al.
EJNMMI Research|June 1, 2017
Monitoring response to anti-angiogenic mTOR inhibitor therapy in vivo using <sup>111</sup>In-bevacizumabNeel Patel, Sarah Able, Danny Allen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 6, 2009
Phase I/II trial of bevacizumab and radiotherapy for locally advanced inoperable colorectal cancer: vasculature-independent radiosensitizing effect of bevacizumabMichael I Koukourakis, Alexandra Giatromanolaki, Helen Sheldon, et al.
Cancer Research|March 15, 2008
Regulation of CXCR4 by the Notch ligand delta-like 4 in endothelial cellsCassin Kimmel Williams, Marta Segarra, Maria De La Luz Sierra, et al.
International Journal of Radiation Oncology, Biology, Physics|July 20, 2002
Hypoxia-inducible factor (HIF1A and HIF2A), angiogenesis, and chemoradiotherapy outcome of squamous cell head-and-neck cancerMichael I Koukourakis, Alexandra Giatromanolaki, Efthimios Sivridis, et al.
Pageof 47